id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0101-1319,FDA,FDA-2015-N-0101,Advice Letter from FDA CDER to American Chemistry Council,Other,Letter(s),2016-12-30T05:00:00Z,2016,12,2016-12-30T05:00:00Z,,2016-12-30T18:11:04Z,,0,0,0900006482442595
FDA-2015-D-0025-0016,FDA,FDA-2015-D-0025,Medical Device Accessories – Describing Accessories and Classification Pathway for New Accessory Types Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2016-12-30T05:00:00Z,2016,12,2016-12-30T05:00:00Z,,2024-11-11T21:31:30Z,,1,0,09000064824410cc
FDA-2016-D-0269-0113,FDA,FDA-2016-D-0269,"Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry",Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-12T06:18:06Z,,1,0,090000648243ddab
FDA-2013-E-0397-0007,FDA,FDA-2013-E-0397,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:24:51Z,,0,0,090000648243dfe0
FDA-2016-V-4616-0002,FDA,FDA-2016-V-4616,Acknowledgement Letter from FDA DDM to LASERSLIVE,Other,Acknowledgement Letter/Receipt,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T22:41:32Z,,0,0,090000648243f2c9
FDA-2016-V-4592-0002,FDA,FDA-2016-V-4592,Acknowledgement Letter from FDA DDM to FOH Ninja,Other,Acknowledgement Letter/Receipt,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T22:38:52Z,,0,0,090000648243c203
FDA-2014-E-0265-0008,FDA,FDA-2014-E-0265,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:00:31Z,,0,0,090000648243db42
FDA-2000-D-0103-0010,FDA,FDA-2000-D-0103,Botanical Drug Development Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-12T06:17:07Z,,1,0,090000648243ddaf
FDA-2016-V-4616-0001,FDA,FDA-2016-V-4616,Variance Application from LASERSLIVE,Other,Application for Variance (VAR),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T22:40:37Z,,0,0,090000648243f28d
FDA-2013-E-0687-0007,FDA,FDA-2013-E-0687,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:16:50Z,,0,0,090000648243df84
FDA-2016-N-3389-0394,FDA,FDA-2016-N-3389,Request to Extend Comment Period from Grocery Manufacturers Association,Other,Electronic Regulation from Form,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:19:26Z,,0,0,0900006482432fb6
FDA-2016-D-4317-0002,FDA,FDA-2016-D-4317,Draft Guidance for Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,2017-02-28T04:59:59Z,2019-08-21T15:09:05Z,,0,0,090000648243ddb2
FDA-2016-V-4617-0001,FDA,FDA-2016-V-4617,Variance Application from Redwolf Entertainment,Other,Application for Variance (VAR),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T23:09:01Z,,0,0,090000648243f1f6
FDA-2016-D-2335-0730,FDA,FDA-2016-D-2335,"Request to Extend Comment Period from Herbalife International of America, Inc.",Other,Request for Extension,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T18:07:39Z,,0,0,0900006482432aa1
FDA-2016-D-2495-0014,FDA,FDA-2016-D-2495,Submission of Warning Plans for Cigars Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-07T23:52:28Z,,1,0,090000648243da71
FDA-2016-V-4592-0001,FDA,FDA-2016-V-4592,Variance Application from FOH Ninja,Other,Application for Variance (VAR),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T22:38:47Z,,0,0,090000648243c201
FDA-2014-E-0126-0011,FDA,FDA-2014-E-0126,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:22:08Z,,0,0,090000648243dfb9
FDA-2016-V-4617-0002,FDA,FDA-2016-V-4617,Acknowledgement Letter from FDA DDM to Redwolf Entertainment,Other,Acknowledgement Letter/Receipt,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T23:09:07Z,,0,0,090000648243f1f9
FDA-2013-E-0968-0007,FDA,FDA-2013-E-0968,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:27:19Z,,0,0,090000648243dfe2
FDA-2013-E-0785-0007,FDA,FDA-2013-E-0785,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:29:41Z,,0,0,090000648243dfe5
FDA-2014-D-0234-0030,FDA,FDA-2014-D-0234,Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-12T06:15:55Z,,1,0,090000648243d98f
FDA-2016-D-4318-0002,FDA,FDA-2016-D-4318,"Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies and Federal Facilities Guidance for Industry
DRAFT GUIDANCE",Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,2017-02-28T04:59:59Z,2024-11-12T06:15:53Z,,1,0,090000648243dd0f
FDA-2013-E-1302-0007,FDA,FDA-2013-E-1302,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:19:45Z,,0,0,090000648243dfb6
FDA-2016-P-4388-0002,FDA,FDA-2016-P-4388,Acknowledgment Letter from FDA DDM to Dr. S. Varghese,Other,Acknowledgement Letter/Receipt,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:33:53Z,,0,0,090000648240c140
FDA-2013-E-0475-0007,FDA,FDA-2013-E-0475,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:06:41Z,,0,0,090000648243db48
FDA-2016-P-4388-0001,FDA,FDA-2016-P-4388,Citizen Petition from Dr. S. Varghese,Other,Citizen Petition,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,2017-06-27T03:59:59Z,2020-12-11T15:25:03Z,,0,0,090000648240c13d
FDA-2009-D-0524-0033,FDA,FDA-2009-D-0524,Listing of Ingredients in Tobacco Products (Revised)* Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2024-11-11T21:31:27Z,,1,0,090000648243d90e
FDA-2014-E-0102-0010,FDA,FDA-2014-E-0102,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:09:08Z,,0,0,090000648243df82
FDA-2014-D-1953-0003,FDA,FDA-2014-D-1953,Providing Regulatory Submissions in Electronic Format—Submission of Manufacturing Establishment Information Guidance for Industry,Other,,2016-12-29T00:00:00Z,2016,12,,,2024-11-12T06:18:05Z,,0,1,090000648243d87f
FDA-2016-P-4587-0001,FDA,FDA-2016-P-4587,Citizen Petition from Mallinckrodt Pharmaceuticals,Other,Citizen Petition,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,2017-06-27T03:59:59Z,2017-05-13T21:06:17Z,,0,0,090000648243b8f5
FDA-2013-E-1652-0007,FDA,FDA-2013-E-1652,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T15:40:58Z,,0,0,090000648243b099
FDA-2013-E-1435-0007,FDA,FDA-2013-E-1435,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T13:27:17Z,,0,0,090000648243a249
FDA-2016-P-4584-0001,FDA,FDA-2016-P-4584,Citizen Petition from Public Citizens Health Research Group,Other,Citizen Petition,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,2017-05-31T03:59:59Z,2016-12-28T21:49:56Z,,0,0,090000648243b3c0
FDA-2014-P-1685-0004,FDA,FDA-2014-P-1685,Petition Denial Letter,Other,Denial of Petition,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T18:59:58Z,,0,0,090000648243b95d
FDA-2014-E-0307-0008,FDA,FDA-2014-E-0307,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T14:15:11Z,,0,0,090000648243a443
FDA-2013-E-1437-0007,FDA,FDA-2013-E-1437,Noice of FInal Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T13:58:12Z,,0,0,090000648243a43d
FDA-2016-P-4585-0001,FDA,FDA-2016-P-4585,"Citizen Petition from Acorda Therapeutics, Inc",Other,Citizen Petition,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,2017-06-27T03:59:59Z,2016-12-28T21:50:52Z,,0,0,090000648243b802
FDA-2013-E-0218-0004,FDA,FDA-2013-E-0218,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T12:48:16Z,,0,0,0900006482439154
FDA-2014-E-0279-0008,FDA,FDA-2014-E-0279,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T19:22:15Z,,0,0,090000648243b985
FDA-2016-E-4590-0001,FDA,FDA-2016-E-4590,"Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc)",Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T18:48:24Z,,0,0,090000648243b930
FDA-2016-E-4588-0001,FDA,FDA-2016-E-4588,"Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc)",Other,Application,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2017-07-18T11:56:50Z,,0,0,090000648243b645
FDA-2014-E-0182-0008,FDA,FDA-2014-E-0182,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T14:43:08Z,,0,0,090000648243a977
FDA-2016-P-4585-0002,FDA,FDA-2016-P-4585,"Acknowledgement Letter from FDA DDM to Acorda Therapeutics, Inc.",Other,Acknowledgement Letter/Receipt,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T21:50:55Z,,0,0,090000648243b804
FDA-2011-E-0117-0010,FDA,FDA-2011-E-0117,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T16:02:09Z,,0,0,090000648243ac83
FDA-2013-E-1433-0007,FDA,FDA-2013-E-1433,Notice of Final Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T19:30:45Z,,0,0,090000648243b987
FDA-2016-E-0629-0004,FDA,FDA-2016-E-0629,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T19:08:09Z,,0,0,090000648243b936
FDA-2014-E-0074-0008,FDA,FDA-2014-E-0074,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T15:15:46Z,,0,0,090000648243af7e
FDA-2016-E-4588-0002,FDA,FDA-2016-E-4588,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T17:45:01Z,,0,0,090000648243b649
FDA-2016-E-4589-0001,FDA,FDA-2016-E-4589,"Patent Extension Application from Cooley LLP (on behalf of Collegium Pharmaceutical, Inc)",Other,Application,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T17:56:06Z,,0,0,090000648243b75c
FDA-2016-P-4587-0002,FDA,FDA-2016-P-4587,Acknowledgement Letter from FDA DDM to Mallinckrodt Pharmaceuticals,Other,Acknowledgement Letter/Receipt,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T21:51:19Z,,0,0,090000648243b8f7
FDA-2013-E-0264-0004,FDA,FDA-2013-E-0264,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T13:18:55Z,,0,0,090000648243a243
FDA-2015-D-2537-0108,FDA,FDA-2015-D-2537,Request to Extend Comment Period from CGA and GAWDA,Other,Request for Extension,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T16:49:10Z,,0,0,090000648243b643
FDA-2016-E-0627-0004,FDA,FDA-2016-E-0627,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T12:38:01Z,,0,0,0900006482439152
FDA-2016-E-4589-0002,FDA,FDA-2016-E-4589,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T18:00:41Z,,0,0,090000648243b3fe
FDA-2014-E-0131-0009,FDA,FDA-2014-E-0131,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T15:30:49Z,,0,0,090000648243b03b
FDA-2016-P-4584-0002,FDA,FDA-2016-P-4584,Acknowledgement Letter from FDA DDM to Public Citizens Health Research Group,Other,Acknowledgement Letter/Receipt,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T21:50:00Z,,0,0,090000648243b3c2
FDA-2013-E-0263-0004,FDA,FDA-2013-E-0263,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T19:15:08Z,,0,0,090000648243b983
FDA-2015-D-5105-0058,FDA,FDA-2015-D-5105,"Postmarket Management of Cybersecurity in Medical Devices
Guidance for Industry and Food and Drug Administration Staff",Other,Guidance,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2024-11-07T23:52:14Z,,1,0,090000648243a974
FDA-2016-E-4590-0002,FDA,FDA-2016-E-4590,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T18:49:00Z,,0,0,090000648243b933
FDA-2015-D-2537-0107,FDA,FDA-2015-D-2537,"Request to Extend Comment Period from Cook Group, Inc.",Other,Request for Extension,2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T16:46:19Z,,0,0,090000648243b1a1
FDA-2014-E-0299-0008,FDA,FDA-2014-E-0299,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T15:52:28Z,,0,0,090000648243b09e
FDA-2016-V-4377-0002,FDA,FDA-2016-V-4377,Acknowledgment Letter from FDA DDM to Eric Cwiak,Other,Acknowledgement Letter/Receipt,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2017-11-29T15:46:13Z,,0,0,090000648240be6d
FDA-2016-V-4377-0001,FDA,FDA-2016-V-4377,Variance Application for Eric Cwiak,Other,Application for Variance (VAR),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2017-11-29T15:46:19Z,,0,0,090000648240b853
FDA-2016-V-4390-0002,FDA,FDA-2016-V-4390,Acknowledgement Letter from FDA DDM to Jellybeams,Other,Acknowledgement Letter/Receipt,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T22:47:31Z,,0,0,090000648240ea4a
FDA-2016-M-4529-0001,FDA,FDA-2016-M-4529,Premarket Approval Response from FDA CDRH to Aptima HIV-1 Quant Assay,Other,Approval,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T12:54:19Z,,0,0,0900006482436620
FDA-2014-E-0950-0004,FDA,FDA-2014-E-0950,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T19:30:41Z,,0,0,09000064824384fb
FDA-2016-V-4390-0001,FDA,FDA-2016-V-4390,Variance Application from Jellybeams,Other,Application for Variance (VAR),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T22:47:21Z,,0,0,090000648240ea48
FDA-2014-E-0944-0004,FDA,FDA-2014-E-0944,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T19:10:39Z,,0,0,09000064824384bf
FDA-2016-D-1495-0015,FDA,FDA-2016-D-1495,"Guidance for Industry on Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions",Other,Guidance,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2024-11-11T21:31:40Z,,1,0,09000064824378a1
FDA-2016-V-4391-0001,FDA,FDA-2016-V-4391,Variance Application from JMH Productions LLC,Other,Application for Variance (VAR),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T22:49:37Z,,0,0,090000648240f0f8
FDA-2016-V-4391-0002,FDA,FDA-2016-V-4391,Acknowledgement Letter from FDA DDM to JMH Productions LLC,Other,Acknowledgement Letter/Receipt,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T22:49:45Z,,0,0,090000648240f0fa
FDA-2012-D-1002-0010,FDA,FDA-2012-D-1002,Draft Guidance for Questions and Answers Regarding Food Facility Registration (Seventh Edition),Other,Guidance,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2024-11-07T23:51:42Z,,1,0,09000064824379f1
FDA-2014-E-0943-0004,FDA,FDA-2014-E-0943,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T19:43:29Z,,0,0,09000064824384fd
FDA-2015-E-4615-0004,FDA,FDA-2015-E-4615,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:45:29Z,,0,0,0900006482438638
FDA-2016-E-2379-0004,FDA,FDA-2016-E-2379,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:16:55Z,,0,0,0900006482438391
FDA-2015-E-4727-0004,FDA,FDA-2015-E-4727,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:56:11Z,,0,0,090000648243847b
FDA-2016-E-1888-0004,FDA,FDA-2016-E-1888,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T18:01:50Z,,0,0,09000064824380f0
FDA-2014-E-0945-0004,FDA,FDA-2014-E-0945,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T19:57:05Z,,0,0,0900006482438900
EPA-HQ-OPP-2016-0036-0002,EPA,EPA-HQ-OPP-2016-0036,Public Participation for VNT1 Protein Late Blight Resistance,Other,Public Participation,2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,2017-01-08T04:59:59Z,2016-12-26T01:35:16Z,,0,0,09000064824345a5
FDA-2014-E-0940-0004,FDA,FDA-2014-E-0940,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:23:22Z,,0,0,0900006482434339
FDA-2015-E-0640-0004,FDA,FDA-2015-E-0640,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:54:27Z,,0,0,09000064824343c6
FDA-2014-E-2362-0004,FDA,FDA-2014-E-2362,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:40:53Z,,0,0,09000064824345a1
FDA-2016-V-4097-0008,FDA,FDA-2016-V-4097,Variance Approval Letter from FDA CDRH to Carestream Dental Company (Trophy),Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T19:06:01Z,,0,0,0900006482434a30
FDA-2015-E-1179-0004,FDA,FDA-2015-E-1179,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T15:58:24Z,,0,0,0900006482433cb3
FDA-2015-E-2604-0004,FDA,FDA-2015-E-2604,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T18:11:12Z,,0,0,09000064824344cc
FDA-2014-E-2363-0004,FDA,FDA-2014-E-2363,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T17:43:43Z,,0,0,09000064824344c4
FDA-2014-E-1653-0004,FDA,FDA-2014-E-1653,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:37:41Z,,0,0,090000648243459f
FDA-2015-E-3854-0004,FDA,FDA-2015-E-3854,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:08:26Z,,0,0,0900006482433cb9
FDA-2015-E-2722-0006,FDA,FDA-2015-E-2722,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T17:05:59Z,,0,0,090000648243468f
FDA-2016-E-0118-0004,FDA,FDA-2016-E-0118,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:26:39Z,,0,0,090000648243436b
FDA-2015-E-4696-0004,FDA,FDA-2015-E-4696,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:17:02Z,,0,0,0900006482434331
FDA-2014-E-2326-0004,FDA,FDA-2014-E-2326,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:36:59Z,,0,0,090000648243459d
FDA-2015-E-4020-0004,FDA,FDA-2015-E-4020,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:32:03Z,,0,0,0900006482434387
FDA-2015-E-2965-0006,FDA,FDA-2015-E-2965,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:29:07Z,,0,0,0900006482434383
FDA-2015-E-4700-0004,FDA,FDA-2015-E-4700,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:17:38Z,,0,0,090000648243452c
FDA-2015-E-4703-0004,FDA,FDA-2015-E-4703,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:28:26Z,,0,0,0900006482434369
FDA-2015-E-2619-0004,FDA,FDA-2015-E-2619,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:43:10Z,,0,0,09000064824343c2
FDA-2015-E-3855-0004,FDA,FDA-2015-E-3855,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:07:22Z,,0,0,0900006482433cb7
FDA-2015-E-2660-0006,FDA,FDA-2015-E-2660,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T17:15:43Z,,0,0,0900006482434443
FDA-2015-E-1665-0004,FDA,FDA-2015-E-1665,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T18:01:04Z,,0,0,09000064824344c8